HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identifying the RNA polymerases that synthesize specific transcripts of the Autographa californica nuclear polyhedrosis virus.

Abstract
Nuclear run-on assays carried out in the presence and absence of the RNA polymerase II inhibitor, alpha-amanitin, were used to determine the exact timing of the switch from inhibitor-sensitive transcription catalysed by host RNA polymerase II, to inhibitor-resistant transcription catalysed by the baculovirus-induced RNA polymerase. These studies revealed that the onset of alpha-amanitin-resistant transcription is just after 6 h post-infection, simultaneous with the beginning of the late phase of infection. They also showed that transcripts from the p26 gene in the HindIII Q/P region and the p35 gene in the HindIII K/Q region of the viral genome are synthesized by the host RNA polymerase II both early and late in infection. On the other hand, transcripts of the p10 gene in the HindIII Q/P region and the gamma transcripts in the HindIII K region are synthesized by the alpha-amanitin-resistant, virus-induced RNA polymerase late in infection.
AuthorsN E Huh, R F Weaver
JournalThe Journal of general virology (J Gen Virol) Vol. 71 ( Pt 1) Pg. 195-201 (Jan 1990) ISSN: 0022-1317 [Print] England
PMID2106003 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Amanitins
  • DNA, Viral
  • Diterpenes
  • RNA, Viral
  • Aphidicolin
  • Cycloheximide
  • RNA Polymerase II
Topics
  • Amanitins (pharmacology)
  • Animals
  • Aphidicolin
  • Blotting, Southern
  • Cycloheximide (pharmacology)
  • DNA Replication (drug effects)
  • DNA, Viral (analysis, biosynthesis)
  • Diterpenes (pharmacology)
  • Insect Viruses (enzymology, genetics)
  • Moths
  • Nucleic Acid Hybridization
  • RNA Polymerase II (analysis, antagonists & inhibitors)
  • RNA, Viral (biosynthesis, drug effects)
  • Transcription, Genetic (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: